(Q39091651)

9 September 2017

title

Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status (English)

1 reference

9 September 2017

0 references

1 reference

Yousra Ibn Yacoub

1

1 reference

9 September 2017

Bouchra Amine

2

1 reference

9 September 2017

Assia Laatiris

3

1 reference

9 September 2017

Fahd Wafki

4

1 reference

9 September 2017

Fatima Znat

5

1 reference

9 September 2017

Najia Hajjaj-Hassouni

6

1 reference

9 September 2017

publication date

27 September 2011

1 reference

Rheumatology International

9 September 2017

published in

1 reference

9 September 2017

volume

32

1 reference

9 September 2017

issue

10

1 reference

9 September 2017

page(s)

3143-3148

1 reference

Erosive arthropathy in systemic sclerosis

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Osteoporosis in scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Vitamin D and autoimmune rheumatologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Vitamin D: its role and uses in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Study of bone density in systemic scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Assessment of pituitary gonadotropin release to gonadotropin releasing hormone/thyroid-stimulating hormone stimulation in women with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

RANK ligand inhibition with denosumab for the management of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

The prognostic factors of systemic sclerosis for survival among Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Control of autoimmune diseases by the vitamin D endocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-011-2150-1

Systemic sclerosis and bone loss: the role of the disease and body composition

21 January 2018

1 reference

12 December 2020

[Bone mineral density and bone turnover in systemic sclerosis]

1 reference

12 December 2020

Bone mineral density in scleroderma

1 reference

12 December 2020

Very low levels of vitamin D in systemic sclerosis patients

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

12 December 2020

Oral calcitriol as a new therapeutic modality for generalized morphea.

1 reference

12 December 2020

Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis

1 reference

12 December 2020

Prognostic factors of low bone mineral density in systemic sclerosis

1 reference

12 December 2020

Criteria for the classification of early systemic sclerosis.

1 reference

12 December 2020

Novel insights in the immune function of the vitamin D system: synergism with interferon-beta

1 reference

12 December 2020

Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.

1 reference

12 December 2020

Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis

1 reference

12 December 2020

Disease and symptom burden in systemic sclerosis: a patient perspective.

1 reference

12 December 2020

Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis.

1 reference

12 December 2020

10.1007/S00296-011-2150-1

Identifiers

DOI

1 reference

9 September 2017

1 reference